97 related articles for article (PubMed ID: 8535218)
1. Regression of experimental human leukemias and solid tumors induced by Epstein-Barr virus-immortalized B cells.
Angiolillo AL; Sgadari C; Sheikh N; Reaman GH; Tosato G
Leuk Lymphoma; 1995 Oct; 19(3-4):267-76. PubMed ID: 8535218
[TBL] [Abstract][Full Text] [Related]
2. Regression of experimental Burkitt's lymphoma induced by Epstein-Barr virus-immortalized human B cells.
Tosato G; Sgadari C; Taga K; Jones KD; Pike SE; Rosenberg A; Sechler JM; Magrath IT; Love LA; Bhatia K
Blood; 1994 Feb; 83(3):776-84. PubMed ID: 8298139
[TBL] [Abstract][Full Text] [Related]
3. Suppression of Burkitt's lymphoma tumorigenicity in nude mice by co-inoculation of EBV-immortalized lymphoblastoid cells.
Wolf J; Draube A; Bohlen H; Jox A; Mücke S; Pawlita M; Möller P; Diehl V
Int J Cancer; 1995 Feb; 60(4):527-33. PubMed ID: 7829268
[TBL] [Abstract][Full Text] [Related]
4. Local growth of a Burkitt's lymphoma versus disseminated invasive growth of the autologous EBV-immortalized lymphoblastoid cells and their somatic cell hybrids in SCID mice.
Walter J; Möller P; Moldenhauer G; Schirrmacher V; Pawlita M; Wolf J
Int J Cancer; 1992 Jan; 50(2):265-73. PubMed ID: 1309726
[TBL] [Abstract][Full Text] [Related]
5. Biology and virology of the human malignant lymphomas: 1st Milford D. Schulz Lecture.
Kaplan HS; Goodenow RS; Gartner S; Bieber MM
Cancer; 1979 Jan; 43(1):1-24. PubMed ID: 83902
[TBL] [Abstract][Full Text] [Related]
6. A role for the interferon-inducible protein 10 in inhibition of angiogenesis by interleukin-12.
Angiolillo AL; Sgadari C; Tosato G
Ann N Y Acad Sci; 1996 Oct; 795():158-67. PubMed ID: 8958926
[TBL] [Abstract][Full Text] [Related]
7. Growth and spread in nude mice of Epstein-Barr virus transformed B-cells from a chronic lymphocytic leukemia patient.
Lee CL; Uniyal S; Fernandez LA; Lee SH; Ghose T
Cancer Res; 1986 May; 46(5):2497-501. PubMed ID: 3008990
[TBL] [Abstract][Full Text] [Related]
8. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
[TBL] [Abstract][Full Text] [Related]
9. Human B-lymphoid cell lines.
Nilsson K
Hum Cell; 1992 Mar; 5(1):25-41. PubMed ID: 1329931
[TBL] [Abstract][Full Text] [Related]
10. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines.
Perez-Chacon G; de Los Rios C; Zapata JM
Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456
[TBL] [Abstract][Full Text] [Related]
11. Burkitt's lymphoma cell line bearing surface IgA and negative for nuclear antigen of Epstein-Barr virus (EBNA).
Hayashi Y; Matsumura Y; Nishihira T; Watanabe I; Ohi R; Kasai M; Kumagai K; Kamada N
Jpn J Exp Med; 1980 Dec; 50(6):423-34. PubMed ID: 6268866
[TBL] [Abstract][Full Text] [Related]
12. Establishment of an Epstein-Barr virus-negative B-cell lymphoma line from a Japanese Burkitt's lymphoma and its serial passage in hamsters.
Miyoshi I; Hiraki S; Kubonishi I; Matsuda Y; Kishimoto H; Nakayama T; Tanaka T; Masuji H; Kimura I
Cancer; 1977 Dec; 40(6):2999-3003. PubMed ID: 201360
[TBL] [Abstract][Full Text] [Related]
13. In vitro Epstein-Barr virus-immortalized lymphoma cell line carrying t(9;14)(p13;q32) chromosome abnormality, derived from splenic lymphoma with villous lymphocytes.
Daibata M; Taguchi T; Nemoto Y; Iwasaki S; Ohtsuki Y; Taguchi H
Int J Cancer; 2006 Jan; 118(2):513-7. PubMed ID: 16049984
[TBL] [Abstract][Full Text] [Related]
14. Athymic nude mice: induction of tumors containing Epstein-Barr virus using Burkitt's-related cell lines.
Ablashi DV; Glaser R; Easton JM; Nonoyama M; Armstrong GR
Exp Hematol; 1978 Apr; 6(4):365-74. PubMed ID: 206453
[TBL] [Abstract][Full Text] [Related]
15. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
[TBL] [Abstract][Full Text] [Related]
16. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
Yokochi T; Holly RD; Clark EA
J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
[TBL] [Abstract][Full Text] [Related]
17. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies.
Westphal EM; Blackstock W; Feng W; Israel B; Kenney SC
Cancer Res; 2000 Oct; 60(20):5781-8. PubMed ID: 11059774
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-18 expression induced by Epstein-Barr virus-infected cells.
Yao L; Setsuda J; Sgadari C; Cherney B; Tosato G
J Leukoc Biol; 2001 May; 69(5):779-84. PubMed ID: 11358987
[TBL] [Abstract][Full Text] [Related]
19. Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis.
Guedez L; McMarlin AJ; Kingma DW; Bennett TA; Stetler-Stevenson M; Stetler-Stevenson WG
Am J Pathol; 2001 Apr; 158(4):1207-15. PubMed ID: 11290537
[TBL] [Abstract][Full Text] [Related]
20. T cell recognition of Epstein-Barr virus associated lymphomas.
Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
